Back to top
more

Merit Medical Systems (MMSI)

(Delayed Data from NSDQ)

$94.35 USD

94.35
239,975

+0.59 (0.63%)

Updated Oct 11, 2024 04:00 PM ET

After-Market: $94.34 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 26% (186 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Becton, Dickinson Banks on Bard Buyout, Medical Unit Weak

by Zacks Equity Research

Becton, Dickinson (BDX) is steadily progressing with the acquisition of C. R. Bard. However, sluggishness in the Medical Segment is a headwind.

    Only 4 Dental Stocks to Buy Amid MedTech Regulatory Woes

    by Zacks Equity Research

    After a stellar five-year run on the bourse, the performance of the dental industry has taken a hit in the last two years.

      Dental Faces Regulatory Challenges: Only 5 Stocks to Pick

      by Zacks Equity Research

      Owing to the adversities in the medical universe, market watchers have adopted a bearish stance toward the dental space. These are the only five dental stocks that are expected to beat the ongoing MedTech gloom.

        AbbVie Inc. (ABBV) in Focus: Stock Moves 6.1% Higher

        by Zacks Equity Research

        AbbVie (ABBV) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.

          Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away?

          by Zacks Equity Research

          Aceto Corporation (ACET) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.

            Merit Medical Systems (MMSI) Worth a Look: Stock Gains 7.7%

            by Zacks Equity Research

            Merit Medical Systems, Inc. (MMSI) shares rose almost 8% in the last trading session.

              Merit Medical Embosphere Gets FDA de novo Classification

              by Zacks Equity Research

              Merit Medical Systems, Inc. (MMSI) recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres from the FDA to expand its indication in the prostatic artery embolization (PAE) space.

                Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering

                by Zacks Equity Research

                Merit Medical Systems, Inc. (MMSI) announced that it has closed its follow-on public offering of 5.2 million shares of common stock at $28.25 per share.

                  Top Ranked Momentum Stocks to Buy for March 30th

                  by Zacks Equity Research

                  Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th:

                    Merit Medical (MMSI) Prices 4.5M Follow-On Share Offering

                    by Zacks Equity Research

                    Merit Medical Systems, Inc. (MMSI) announced that it has priced its follow-on public offering of 4.5 million shares of common stock at $28.25 per share.

                      Merit Medical (MMSI) to Refinance Debt via Share Offering

                      by Zacks Equity Research

                      Merit Medical Systems, Inc. (MMSI) announced that it has commenced a follow on public offering of its common stock.

                        MedTech Stocks Earnings Slated on Feb 21: MDT, HSIC and More

                        by Zacks Equity Research

                        Let's take a look at the major MedTech stocks slated to release their Oct-Dec 2016 numbers on Feb 21.

                          Merit Medical Hits 52-Week High: What's Driving the Stock?

                          by Zacks Equity Research

                          Share price of South Jordan, Utah-based Merit Medical Systems, Inc. (MMSI) reached a fresh 52-week high of $26.80 on Dec 9, finally closing a tad lower at $26.60.